Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Esprit Pharma Inc.

Division of Allergan PLC

Latest From Esprit Pharma Inc.

Biopharma VCs Move to the Middle in 2006

While the venture capital community spent roughly the same in biopharma investments in 2006 as they did in 2005, they put considerably more money into mid-stage companies (Series B and C investments), and slightly less into Series A and mezzanine rounds, than they had in 2005.
BioPharmaceutical Business Strategies

Attack of the Killer Bs

2006 has seen an unusual number of large Series B venture rounds in biopharma compared to last year, though Series B rounds haven't been much larger on average.
BioPharmaceutical Strategy

The A-List: 2005's Trend-Shaping Series A Financings

2005's top early stage venture financings reflect a drive for size and experience on the biotech side, and the demand for less-invasive procedures in the device world. Start-Up lists the top ten Series A rounds of 2005.
BioPharmaceutical Medical Device

Selected Start-Ups (7/05)

In Vivo briefly summarizes the technologies of these recently founded companies: Aeres, Azaya Therapeutics, Cellular Dynamics International, Esprit Pharma, InterveXion Therapeutics and Knopp Neurosciences.
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Saturn Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • John T Spitznagel, Chmn. & CEO
    Andrew J Einhorn, CFO
    Christopher Dowd, SVP, Sales
    Nanske Wood, SVP, Strategic Planning & Bus. Dev.
  • Contact Info
  • Esprit Pharma Inc.
    Phone: (732) 828-9950
    Two Tower Ctr.
    East Brunswick, NJ 08816